Surgical Consideration of In Situ Prosthetic Replacement for Primary Infected Abdominal Aortic Aneurysms  by Lai, C.-H. et al.
Eur J Vasc Endovasc Surg (2011) 42, 617e624Surgical Consideration of In Situ Prosthetic
Replacement for Primary Infected Abdominal
Aortic AneurysmsC.-H. Lai a,b,c,d, C.-Y. Luo b,c, P.-Y. Lin a,b,c,d, C.-D. Kan a,c, R.-S. Chang e,
H.-L. Wu b, Y.-J. Yang b,c,*a Institute of Clinical Medicine, National Cheng Kung University College of Medicine and Hospital, Tainan, Taiwan
bCardiovascular Research Centre, National Cheng Kung University College of Medicine and Hospital, Tainan, Taiwan
cDepartment of Surgery, National Cheng Kung University College of Medicine and Hospital, Tainan, Taiwan
dDepartment of Surgery, National Cheng Kung University College of Medicine and Hospital, Dou-Liou Branch,
Yunlin, Taiwan
eDepartment of Radiology, National Cheng Kung University College of Medicine and Hospital, Dou-Liou Branch,
Yunlin, Taiwan
Submitted 19 April 2011; accepted 5 July 2011
Available online 16 August 2011KEYWORDS
Infected aneurysm;
Primary aortoiliac
infection;
In situ reconstruction;
Surgical techniques;
Surgical outcome* Corresponding author. Y. -J. Yang,
Sheng-Li Road, Tainan 704, Taiwan. T
E-mail address: d303878@mail.hos
1078-5884/$36 ª 2011 European Socie
doi:10.1016/j.ejvs.2011.07.005Abstract Objectives: To review our surgical experience of primary infected abdominal aortic
aneurysms, with the aim of assessing the safety and durability of in situ prosthetic replace-
ment.
Design: Retrospective study in a university hospital.
Materials and Methods: Thirty-four patients who underwent surgery for primary infected
abdominal aortic aneurysms over the past 18 years were reviewed. Operative details and
outcomes were recorded for analysis.
Results: There were six suprarenal and 28 infrarenal infections. Salmonellae (18 patients)
were the most common pathogens. Thirty patients underwent in situ prosthetic replacement,
two underwent extra-anatomic bypass and two underwent endovascular repair. The surgical
mortality for overall patients was 18%, and for patients reconstructed in situ, 17%. Among
the 30 patients reconstructed in situ, four patients who underwent concomitant gastrointes-
tinal procedures (e.g., repair of the duodenal defect) died. By contrast, 25 of 26 patients
without gastrointestinal involvement survived surgery. After a median follow-up period of
58 months, two discharged patients who underwent in situ reconstruction died of late graft
infection.Department of Surgery, National Cheng Kung University College of Medicine and Hospital, No. 138,
el.: þ886 6 2353535x5602; fax: þ886 6 2766676.
p.ncku.edu.tw (Y.-J. Yang).
ty for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
618 C.-H. Lai et al.Conclusions: Our experience suggests that in situ prosthetic replacement can be performed
safely with durable outcomes in the majority of patients with infected abdominal aortic aneu-
rysms. Nevertheless, we advise caution when considering this technique with concomitant
gastrointestinal procedures.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Infected aortic aneurysms are rare diseases that present
challenging scenarios to clinicians. Affected patients
usually present with non-specific manifestations, and
a delay in diagnosis until severe sepsis or aneurysm
rupture occurs is not uncommon.1e9 Despite advances in
medical and surgical treatment, reported morbidity and
mortality remain high. Large series and literature reviews
have documented hospital mortality rates of 16e42%, and
the vast majority of deaths are attributed to sepsis or
rupture.1e13 Among the patients who survive until
discharge, a significant proportion may develop recurrent
infection.4e6,13e15
A combination of aneurysm resection and effective
antibiotic therapy is believed to be the mainstay of
treatment for infected aortic aneurysms. Distal perfusion
can be restored by either in situ reconstruction or extra-
anatomic bypass. Traditionally, the surgical principle
consists of aortic ligation, excision of all infected tissue
and extra-anatomic bypass through a remote non-infected
field.6,10,14,17 This approach is substantially flawed by
inferior patency, the necessity for future reconstruction
and, most importantly, the continuing risk of stump
blowout.4,10,14,17,18 Over the past two decades, in situ
reconstruction has gradually become the standard proce-
dure, based on promising results repeatedly reported in
surgical literature.6,11,14,18e20 However, in situ recon-
struction is recommended only in patients with controlled
infection, minimal purulence or elective surgery after
prolonged antibiotic administration.1,2,5,6,17,21 Graft
contamination remains a major concern when surgeons
select in situ reconstruction.
Clinically, infected aneurysms in the abdominal aorta
differ from their thoracic counterparts in many respects,
including their anatomy and associated surgical consider-
ations.2,22 Due to their infectious nature, infected
abdominal aortic aneurysms are occasionally complicated
by the involvement of anatomically adjacent structures,
for example, the psoas muscles, vertebral bodies, inferior
vena cava and gastrointestinal tract.1e7,10,12,13 Reciprocal
infections between infected aneurysms and contiguous
structures represent extensive periaortic infections that
not only require additional debridement and repair but
also potentially increase the risk of graft infection.
Whether in situ reconstruction can be performed safely in
every patient with an infected abdominal aortic aneu-
rysm, especially in the presence of extensive infection,
remains uncertain. This study reviews our experiences
with a series of 34 patients undergoing surgery for primary
infected abdominal aortic aneurysms, with the aim of
assessing the safety and durability of in situ prosthetic
replacement.Patients and Methods
We searched our vascular surgery database to identify 34
consecutive patients with primary infected aneurysms in
the abdominal aorta between July 1993 and March 2010. All
patients (1) presented preoperatively with clinical symp-
toms/signs of infection (fever, pain, and leucocytosis), (2)
had typical findings (periaortic inflammation, rapid aneu-
rysm progression on sequential CT and periaortic gas) in
contrast-enhanced computed tomography (CT) and (3) had
either a positive preoperative blood culture or intra-
operative tissue culture or both. In patients undergoing
open repair, the diagnosis was further confirmed with
surgical findings (inflammation and purulence). Culture-
negative patients were not included in this series. Patients
with infected aneurysms secondary to prosthetic graft
infections were excluded from this study.
For all patients, the following data were recorded: age,
gender, clinical presentation, underlying diseases,
anatomic location of the aneurysm, results of blood and
tissue cultures, operative findings and techniques, duration
of antibiotic therapy and early and late outcomes. This
study was approved by the local institutional review board.
Statistical analysis
Comparisons between groups were performed using the c2
test or Fisher’s exact test. Statistical analyses were per-
formed using the Statistical Package for the Social Sciences
for Windows, Version 12.0 (SPSS, Chicago, IL, USA), and
P < 0.05 was considered significant.
Results
Patients, clinical presentations and pathogens
During the 18-year period of this study, 28men and six women
with infected abdominal aortic aneurysms underwent surgery
in our hospital. Themedian patient agewas 69 (range, 37e80)
years. All of the patients were symptomatic. Patient charac-
teristics are summarised in Table 1. Culture results were
obtained from blood only (13 patients), tissue only (7) or both
(14). Salmonellae (18 patients) were the most common
pathogens. Other causativepathogens are detailed inTable 2.
CT findings
Sequential CT studies of the six patients who were initially
reluctant to undergo surgery revealed radiologic evidence
of disease progression. At the latest preoperative CT
imaging, saccular-type aneurysms were present in 26
Table 1 Patient characteristics and clinical data of the 34 patients.
Variables N %
Male sex 28 82%
Aneurysm location
Suprarenal aorta 6 82%
Infrarenal aorta 28 18%
Manifestation
Fever 24 71%
Shock 11 32%
Pain 33 97%
Consciousness disturbance 7 21%
Comorbidity
Diabetes 13 38%
Hypertension 9 26%
Coronary artery disease 5 15%
Chronic obstructive pulmonary disease 4 12%
Peptic ulcer disease 3 9%
Uremia 3 9%
Cerebrovascular disease 2 6%
Liver cirrhosis 1 3%
Iatrogenic Cushing’s syndrome 1 3%
Hypertrophic obstructive cardiomyopathy 1 3%
Surgical strategy
Open repair 32 94%
In situ reconstruction 30 88%
Celiac trunk 2 6%
Inferior mesenteric artery 2 6%
Left renal artery 1 3%
Extra-anatomic bypass 2 6%
Endovascular repair 2 6%
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existing fusiform aneurysm was present in one patient (3%).
Infection extending to neighbouring retroperitoneal struc-
tures, including psoas muscles abscess or spondylodiscitis
(Fig. 1), was noted in eight patients (25%). Gas collection
and massive perianeurysmal haemorrhage were each
present in five patients (16%).
Perioperative management and operative details
Once the diagnosis of an infected aneurysm was estab-
lished, broad-spectrum intravenous antibiotics (e.g., third-Table 2 Causative pathogens of infected aneurysms of the 34 p
Organism
Salmonella species
Serogroup B
Serogroup C
Serogroup D
Escherichia coli
Methicillin-resistant Staphylococcus aureus
Coagulase-negative Staphylococcus
Streptococcus viridans
Klebsiella pneumoniae
Streptococcus pneumoniae
Campylobacter jejuni
Enterobacter aerogenesgeneration cephalosporins) were administered and surgery
was scheduled as early as possible. Emergency surgery was
conducted for patients presenting with shock or persistent
pain.
Thirty-two patients underwent open surgery. At surgery,
the aneurysm, necrotic periarterial tissue, retroperitoneal
haematoma and purulent material were radically removed
after vascular control was achieved. Rupture with
surrounding haematoma was present in 17 patients (53%).
Eight patients required additional debridement of psoas
muscle abscess and/or lumbar sequestrectomy based on
the CT and operative findings.atients.
N %
18 53%
9 26%
5 15%
4 12%
4 12%
3 9%
2 6%
2 6%
2 6%
1 3%
1 3%
1 3%
Figure 1 Contrast-enhanced CT scan showed an infected
infrarenal aortic aneurysm with coexistence of bilateral psoas
muscle abscess (arrows) and vertebral body destruction
(arrowheads).
620 C.-H. Lai et al.With regard to the management of distal reperfusion,
all except two patients with infrarenal infection under-
went in situ reconstruction. For the two patients who were
reconstructed extra-anatomically, an axillo-bifemoral
bypass was conducted following emergency aortic ligation
to control active haemorrhage. Collectively, in situ
reconstruction using tube or bifurcated Dacron grafts
(Hemashield, Boston Scientific/Meadox Medicals, Oakland,
NJ, USA) was performed in 30 patients and extra-anatomic
bypass was performed in two patients. The Dacron grafts
were not soaked in rifampin or disinfectant solutions.
Cryopreserved allografts were not used due to lack of
availability. Early in this study, we prepared a flap-like
omentum with a preserved blood supply to confer
protection against graft infection if purulent material was
present before debridement. In the past 6 years, omental
flap transposition has been used as a routine adjunct
procedure whenever feasible. Overall, omental flaps were
used in 21 patients (66%). Four of the patients recon-
structed in situ underwent concomitant gastrointestinal
procedures (Table 3). The fragile duodenal defects in these
patients were repaired with interrupted silk sutures and
omental flap transposition was used to cover the defects.
Among the four patients undergoing concomitant gastro-
intestinal procedures, three patients also required
debridement of psoas muscle abscess.Table 3 Clinical data for four patients who underwent in situ
No. Age Sex Causative
pathogen
Location Gastroi
involve
1 80 M Staphylococcus
epidermidis
Infrarenal Necros
proxim
2 70 F Klebsiella
pneumoniae
Infrarenal Duoden
3 71 M Salmonella,
serogroup B
Infrarenal Aortod
4 52 M Salmonella,
serogroup D
Infrarenal DuodenEndovascular repair using Zenith modular stent grafts
(Cook, Bloomington, IN, USA) was performed in two
patients, whose infected aneurysms were located in the
infrarenal aorta. The pathogen (serogroup D Salmonella) of
the two patients was preoperatively identified by blood
culture and both patients responded excellently to initial
antibiotics. No drainage or additional procedures were
performed.
Postoperatively, pathogen-specific antibiotics were
chosen on the basis of the culture results. The duration of
intravenous antibiotic administration, usually 4e8 weeks,
was based on clinical response, laboratory data and
recommendations from infectious disease specialists. Oral
antibiotics were given following discharge, usually for 2e6
months. None of the patients received lifelong antibiotics.Early (surgical) outcomes
The overall surgical mortality rate was 18% (6/34). The
mortality rates were not significantly different among
patients with suprarenal (1/6, 17%) versus infrarenal (5/28,
18%; P > 0.999) abdominal aortic aneurysms.
Five (17%) of the 30 patients who underwent in situ
reconstruction died after surgery. The only surgical
mortality among the six patients with suprarenal infection
was a 76-year-old woman with infection caused by Staph-
ylococcus aureus. This patient developed a sudden anas-
tomotic disruption after persistent methicillin-resistant
Staphylococcus aureus septicaemia and expired during
reoperation due to uncontrolled bleeding. Of the 24
patients who underwent in situ reconstruction for infrare-
nal infection, four patients who underwent concomitant
gastrointestinal procedures died (Table 3). By contrast, 20
patients without gastrointestinal involvement survived
surgery. Collectively, for patients reconstructed in situ, 25
of 26 patients (96%) without gastrointestinal involvement
survived surgery. The major surgical complications
observed in survivors included prolonged adhesive ileus
requiring enterolysis in one patient and respiratory failure
necessitating prolonged ventilatory support in another
patient. There was no perioperative intestinal ischaemia,
limb loss or dialysis-requiring acute renal failure. Of the
two patients who underwent extra-anatomic bypass, one
patient died of multiple organ failure, secondary to intra-
operative bleeding and ongoing sepsis. The other patientreconstruction and concomitant gastrointestinal procedures.
ntestinal
ment
Concomitant gastrointestinal
procedure
Cause of
death
is of
al jejunum
Resection and end-to-end
anastomosis
Sepsis
al defect Direct repair of the
duodenal defect
Intra-op
bleeding
uodenal fistula Direct repair of the
duodenal defect
Feeding jejunostomy
Sepsis
al defect Direct repair of the
duodenal defect
Sepsis
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eventually survived to be discharged.
The two patients treated with endografting recovered
well without complications.
Late outcomes
There were 28 discharged survivors, including 25 patients
with in situ reconstruction. The median follow-up for dis-
charged patients was 58 (range, 4e183) months. Follow-up
was completed for 32 patients (94%). Of the eight patients
who underwent debridement of psoas muscle abscess and/
or lumbar sequestrectomy, five patients without gastroin-
testinal involvement survived to discharge. All five patients
were free from graft infection after a median follow-up of
49 (range, 12e141) months. During the follow-up period,
two discharged patients died of late graft infection. One
73-year-old man initially had an infrarenal infection caused
by Enterobacter aerogenes. This patient died of massive
gastrointestinal bleeding, possibly caused by a secondary
aortoenteric fistula, at 12 months. One 72-year-old man
initially had an infected infrarenal aortic aneurysm caused
by Salmonella serogroup B. This patient developed
a secondary aortoduodenal fistula through the reimplanta-
tion site of the inferior mesenteric artery 25 months after
surgery. Immediately after reoperation, he died of
depressed cardiac output associated with underlying
hypertrophic obstructive cardiomyopathy. Two patients
treated with endovascular repair have been well for 8 and
24 months postoperatively. Follow-up CT of both patients
confirmed regression of the infected aneurysms without
signs of endoleak or stent-graft migration. Other discharged
patients, including the survivor who underwent extra-
anatomic bypass, did not experience any aneurysm-
related events during the follow-up period.
In summary, the rate of incidence of late aneurysm-
related mortality among discharged survivors undergoing
in situ reconstruction was 8% (2/25). Fig. 2 summarises the
surgical procedures and outcomes of the 34 patients in this
study. The overall aneurysm-related mortality rate for
patients in this study was 24% (8/34), and for patients
reconstructed in situ, 23% (7/30). Among the 30 patientswho
underwent in situ reconstruction, infection complicatedFigure 2 Summary of the surgical procedby gastrointestinal involvement was associated with higher
incidences of surgical mortality (100 vs. 4%; PZ 0.0002) and
overall aneurysm-related mortality (100 vs. 12%, PZ 0.001)
than infection without gastrointestinal involvement.Discussion
It is widely accepted that, for suprarenal infection, in situ
reconstruction is the most feasible and preferred surgical
option due to the necessity for visceral revascularisation in
this difficult anatomic region.1e3,23 For patients with
infrarenal infection, controversy concerning the manage-
ment of distal revascularisation still exists. Conducting an
impartial clinical comparison between in situ reconstruc-
tion and extra-anatomic bypass is almost impossible due to
the rarity of infected aortic aneurysms, prior knowledge of
possible risks following the two procedures and potential
bias in patient selection. Upon recent studies reported in
the surgical literature,1,2,5,6,13,19,21 most surgeons per-
formed in situ reconstruction only under conditions of
controlled infection or limited contamination. This reflects
general concerns regarding graft infection following in situ
reconstruction. Indeed, although a significant incidence of
major procedure-specific complications (e.g., aortic stump
disruption and limb loss) has been described, some
surgeons (Table 4) still prefer extra-anatomic bypass
because revascularisation is performed remotely to the
infection site, attenuating the risk of graft contamina-
tion.8,10,17,18,21 The ideal choice between in situ recon-
struction and extra-anatomic bypass depends on the
experience of the surgeon, the condition of the patient
and, most importantly, whether the operative field after
aggressive debridement is sterile enough for in situ recon-
struction. To date, a consensus regarding when to use or
not to use in situ reconstruction has not been unequivocally
established. Our experience with almost generalised
adoption of in situ prosthetic replacement may help to
clarify this unresolved issue.
Our study demonstrates the clinical impact of gastroin-
testinal involvement in patients with infected abdominal
aortic aneurysms. The requirement of concomitant
gastrointestinal procedures was associated with surgicalures and outcomes of the 34 patients.
Table 4 Literature review of primary infected abdominal aortic aneurysms.
First author, year N Mean or
median
age
(year)
Aneurysm
location
(suprarenal/
infrarenal
/iliac, n)
Surgical strategies
and graft selection
Surgical
mortality
Overall
aneurysm-related
mortality
Mean or
median
follow-up
(month)
Fichelle,4 1993 25 63 0/25/0 ISR with Dacron grafts
(n Z 21)
ExAB (n Z 4)
20% 24% 50
Sessa,14 1997 18 70 0/18/0 ISR (n Z 13)
ExAB (n Z 5)
11% 16% 16
Moneta,21 1998 17 NA 7/10/0 ISR with
prosthetic grafts (n Z 4),
and patch aortoplasty
(n Z 3)
ExAB (n Z 10)
23% 23% 24
Hsu,6 2007 33a 71 0/29/4 ISR with Dacron grafts
(n Z 32)
EVR (n Z 1)
15% 24% 22
Woon,17 2008 18 62 0/16/2 ExAB (n Z 18) 33% 39% 34
Dubois,11 2010 44 67 9/33/2 ISR with
Dacron grafts
(n Z 10),
silver impregnated
Dacron graft (n Z 13)b,
homograft (n Z 8),
and autologous deep vein
(n Z 5)
ExAB (n Z 6)
Combined ISR and EAB
(n Z 1)
EVR (n Z 1)
23% 27% 53
Kwon,34 2010 9 65 0/9/0 ISR with
polytetrafluoroethylene
grafts (n Z 9)
11% 11% 49
Lee,8 2011 28 65 0/28/0 ISR with Dacron grafts
(n Z 13)
ExAB (n Z 15)
18% 18% 22
Lai (current study) 34 69 6/28/0 ISR with Dacron grafts
(n Z 30)
ExAB (n Z 2)
EVR (n Z 2)
18% 24% 58
ISR e In situ reconstruction, ExAB- Extra-anatomic bypass, EVR- Endovascular repair, NA- not available.
a Seven patients who received medical treatment only were not included.
b In 18 of the 23 patients treated with a Dacron or silver impregnated Dacron graft, the graft was soaked in Rifampycin.
622 C.-H. Lai et al.mortality and overall aneurysm-related mortality in
patients who underwent in situ prosthetic replacement. In
our experience, patients with duodenojejunal invasion
tended to present with shock and rupture simultaneously,
both of which may further aggravate disease severity.
Infection in these patients disseminated extensively into
the peritoneal cavity, far more serious than limited peri-
aortic contamination with a sterile peritoneal cavity. In
addition, repair of a large duodenal defect surrounded by
unhealthy inflammatory tissue rather than a well-formed
fistula is technically challenging, potentially leading to
bowel leakage, persistent intra-abdominal sepsis and
graft infection.14,24,25 These findings suggest thatgastrointestinal involvement most likely signifies a very
advanced stage of the infected aneurysms.
Due to the limited number of cases reported in the
literature, the ideal management for infected aneurysms
complicated by gastrointestinal involvement remains
undetermined. Even with aggressive debridement, our
experience with in situ prosthetic replacement in such
a hostile operative field was dismal. Accordingly, we
emphasise extreme caution when considering this tech-
nique in the presence of gastrointestinal involvement.
Sufficient peritoneal drainage combined with extra-
anatomic bypass or in situ reconstruction using a conduit
that has greater bacterial resistance (e.g., a cryopreserved
In Situ Reconstruction for Infected Aneurysms 623arterial allograft) might improve the surgical outcomes in
these difficult cases.20,25,26
By contrast, with aggressive debridement and prolonged
use of intravenous antibiotics, in situ prosthetic replace-
ment provided favourable outcomes in patients without
concomitant gastrointestinal procedures. Among 26
patients without gastrointestinal involvement, only one
with suprarenal infection died after surgery. Among 20
patients who underwent in situ reconstruction for infrare-
nal infection, there was no surgical mortality. In this study,
we have continued the use of traditional Dacron grafts in
conjunction with several technical adjuncts. Omental flaps
help to separate the grafts and anastomoses from the
contaminated surgical plane as well as to fill dead
space.2,4,14,19 In addition, the highly-vascularised tissue
flap also acts as a protective dressing containing systemic
antibiotics. Antibiotic-impregnated fibrin glue and local
administration of antibiotics may also be useful for this
purpose.16,20 Since a late graft infection associated with
the reimplantation site of the inferior mesenteric artery
occurred, we relocated the distal anastomoses of bifur-
cated grafts into the groin area to reduce the number of
intra-field anastomoses. The grafts were rerouted to lie in
a track outside the original contaminated plane. These
technical modifications may help to prevent prosthetic
grafts from direct contact with residual purulence and
reduce the occurrence of graft infection. As shown in Table
4, a variety of graft modifications and conduits (e.g.,
antibiotic-soaked prostheses) have been introduced for in
situ reconstruction in the setting of primary aortoiliac
infection.2,11 These grafts provide alternative options with
superior resistance to bacteria.11,27,28
Previous studies have described the impact of coexisting
psoas muscle abscess5 or infective spondylodiscitis29 on
patients with infected aneurysms. These conditions repre-
sent extensive retroperitoneal infection and were regarded
as relative contraindications to in situ reconstruction.
Despite the small number of cases, our experience with in
situ reconstruction in these cases was promising. Adequate
debridement following a detailed and thorough preopera-
tive assessment using CT imaging, which accurately illus-
trates the infected aneurysm and the extent of
retroperitoneal involvement, makes in situ prosthetic
replacement a potential option in the presence of psoas
muscle abscess or infective spondylodiscitis.4,10,30
More recently, the success of endovascular repair as
a less invasive alternative for the treatment of aortic
aneurysms has inspired surgeons to extend this approach to
infected pathologies.9,22,31e33 Although a systematic review
based on sporadic cases yielded a 30-day survival rate of
89.6%,32 a suspicion of publication bias has emerged.33
Furthermore, late aneurysm-related mortalities and
complications are frequent, mainly associated with inade-
quate control of infection. Therefore, an excellent
response to preoperative antibiotics is necessary, as anti-
biotic treatment is the major, if not the only, method for
eradicating infection.32,33 Currently, the safety and dura-
bility of endovascular repair for the treatment of infected
aneurysms, especially for patients with an extensive peri-
aortic infection, remain uncertain. In this study, we
observed two cases successfully managed by endovascular
repair.Because only a few studies have established results for
late aneurysm-related events, no consensus has been
reached regarding the post-discharge duration of oral
antibiotic therapy.1e5,14,17,21,34 Without lifelong antibi-
otics, the rate of incidence of late aneurysm-related
mortality was 8% among survivors who underwent in situ
reconstruction. This result is not inferior to those from
studies of patients on lifelong antibiotic maintenance.2,3,15
Moreover, the effectiveness of oral antibiotic therapy in the
prevention of recurrent infection and associated late
events remains undetermined.3 The potential for the
emergence of resistant strains or other unexpected infec-
tions following long-term oral antibiotics is another
concern,35,36 especially for elderly, debilitated, and
immunocompromised patients. For patients with no
evidence of active infection, we consider the administra-
tion of lifelong antibiotics to be unnecessary.
Our study is limited by its retrospective design and
a relatively small number of cases. These two limitations
are inherent to the study of primary infected aneurysms, as
evidenced in other relevant reports.1e5,14,17,18,21 However,
this study consists of a large single-centre surgical cohort of
infected abdominal aortic aneurysms with longitudinal
follow-up. The operative details may help to distinguish the
safeguards and pitfalls associated with in situ prosthetic
replacement and to improve surgical outcomes for infected
abdominal aortic aneurysms.
In conclusion, our experience with in situ reconstruction
for patients without gastrointestinal involvement suggests
that this technique can be safe and durable for the majority
of patients with primary infected abdominal aortic aneu-
rysms. Nevertheless, extra caution is required when
considering in situ prosthetic replacement with concomi-
tant gastrointestinal procedures.Conflict of Interest/Funding
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